RxSight, Inc. to Present at the Bank of America Healthcare Conference

RxSight, Inc., a company specializing in customizable intraocular lenses for cataract surgery, announced it will participate in the Bank of America Healthcare Conference with management presenting during a fireside chat. The presentation will be available via webcast on RxSight's investor relations website.

RXST

Summarize with

ChatGPT Perplexity Claude Grok Gemini

Key Points

RxSight develops the Light Adjustable Lens system, the first and only intraocular lens technology adjustable after cataract surgery, offering customized vision correction.
The company is increasing investor engagement through participation in a major healthcare conference, signaling ongoing transparency and communication.
This event highlights RxSight’s innovation in the ophthalmic medical device sector, particularly impacting medical devices and healthcare markets.

ALISO VIEJO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., today announced plans to participate in the upcoming Bank of America Healthcare Conference. Management is scheduled to participate in a fireside chat on Wednesday, May 13, 2026, at 3:00 p.m. Pacific Time. A live and archived webcast of the presentation will be available on the company’s investor relations website at https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com

Risks

Uncertainty around market adoption and competitive response to the Light Adjustable Lens technology impacting future sales.
Dependence on successful clinical outcomes and regulatory compliance in the medical device sector.
Potential volatility in investor sentiment due to the presentation’s effect on perceived growth prospects in the ophthalmic device market.

Menu

RxSight, Inc. to Present at the Bank of America Healthcare Conference

Key Points

Risks

More from Press Releases